Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoster Vaccination in Chronic Hepatitis C
NCT02590068Terminated
- Sponsor
- The Rockefeller University
- Start
- Dec 2015
- Primary completion
- Sep 2017
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label trial of zoster vaccine, live in herpes zoster (HZ) (2 arms), sponsored by The Rockefeller University. Primary endpoint: Serum Zoster Antibody Level at 18 months. Started Dec 2015; status: terminated.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02590068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590068.